Case Study 1: Red Cell Exchange

Size: px
Start display at page:

Download "Case Study 1: Red Cell Exchange"

Transcription

1 Case Study 1: Red Cell Exchange Education Session VI: Pediatric Apheresis Leon Su, MD Section Chief, Transfusion Medicine and Apheresis

2 None Disclosures

3 8 year old female SCD History of CVA in 2012 Hgb S levels well maintained on chronic tx (20-30%) Ferritins and Iron in liver (MRI quantification) elevated despite chelation therapy Began chronic exchange therapy in early 2015 Patient HM

4 When to consider outpatient red cell exchange (Sickle cell disease, non-acute) Stroke prophylaxis/iron overload prevention ASFA Category II, Recommendation 1C Vaso-occlusive pain crises ASFA Category III, Recommendation 2C Pre-Op management ASFA Category III, Recommendation 2A Exchange Transfusion Reduced transfusional iron Unrestricted by baseline HCT with ability to target end HCT Multiple donor exposures Simple Transfusion Iron overload more common Restricted to lower baseline HCTs to avoid high viscosity Less donor exposure Schwartz et al. J. Clin Apheresis 28: , 2013 Kim et al. Blood 83(4): , 1994

5 Access Options Peripheral access 18 gauge dialysis-type steel needles 18 to 20 gauge angiocaths AV fistula and grafts Central venous catheters Tunneled and Nontunneled Ports (indicated for power injection) Single and bilateral Dual lumen

6 Double lumen ports 9.5 Bard powerport: ml/min 11.4 Angiodynamics dual lumen smart port: ml/min Considerations when choosing port Previous history of clots and infections History of peripheral access Evaluation by apheresis nurses Appropriate size based on patient

7 Preparing a child for port access: child life support resources They looked into my mouth and into my ears; they looked into my eyes and touched my tummy. But, they never looked at me. (7 year old patient)

8 What is a Child Life Specialist? Assist children in managing/understanding healthcare experiences Assessment Play: therapeutic play, medical play, developmental play Preparation Coping strategies Pre-admission tours Educate End of Life/ Bereavement work Sibling support Back to school Supervise

9 Child Life Support

10 Initial access

11 Ready for exchange

12 Blood Product Selection HM is DcE/DcE with antibody to little e. Requires C, K, Fy(a), Jk(b), S and little e negative blood Institutional Guidelines Type and screen 1-3 days prior to exchange Rh and Kell matched if negative screen Also Fy, Jk and S matched if positive screen Hgb S negative, no irradiation unless other indication < 14 days old Communication with blood bank and blood provider paramount to ensure availability of blood

13 Prime versus nonprime Extracorporeal volume (ECV) Blood warmer volume (BWV) 10-15% of TBV should not exceed ECV + BWV If not priming, intraprocedure HCT can be calculated Optia Prime with saline/albumin during RBCX results in a mix of replacement fluid (RBCs) with saline/albumin in the return line to a HCT = patient

14 Monitoring Hgb S and procedure parameters Pre and post Hgb S levels Target pre procedure Hgb S levels below 30% HM fluctuates between 10-30% pre and post procedure Frequency start at every 4 weeks Typical FCR 40% AC infusion rate 1.1 with 15 mg/kg/hr Calcium Gluconate or AC infusion rate 0.8 with no calcium WB:AC ratio 15:1

15 Ferritin Iron (mg) Procedure 14 and 15 had frequency of 5 weeks before procedure Pre HCT Post HCT Depletion performed with procedures 4, 12 and 13 Minimizing iron gain Lower end target HCT Combining with depletion End target HCT what s the right target?

16 Adverse reactions HM tolerates procedures well and has not had any adverse events over her 1.5 year course Premedicated with Tylenol and Benadryl Other patients with hypotensive reactions and allergic reactions Managed with corticosteroids and fluid boluses, one patient with washed red cells

17 Summary HM continues to have good Hgb S control at 4 week interval RBCX Her Ferritins came down from the 1500s to the s with exchange and better compliance with iron chelation therapy. Plan is to keep at 4 week intervals which will hopefully help pre procedure HCTs stay >24% and allow for modest depletion with exchanges May require splenectomy down the road

18 Thank you!

Therapeutic apheresis (introduction) Orieji Illoh, MD November 21, 2006

Therapeutic apheresis (introduction) Orieji Illoh, MD November 21, 2006 Therapeutic apheresis (introduction) Orieji Illoh, MD November 21, 2006 Apheresis Removal of blood Separation into component parts One component is retained and remainder is returned History First tried

More information

Review of New Platforms for Blood Prime

Review of New Platforms for Blood Prime Review of New Platforms for Blood Prime Edwin A. Burgstaler, MT, HP(ASCP) ASFA 2015 Annual Meeting May, 2015 2015 MFMER slide-1 Objectives The participant will recognize the basic steps in performing a

More information

Disclosure. Presented analysis part of larger study funded by Terumo BCT

Disclosure. Presented analysis part of larger study funded by Terumo BCT 1 Comparison of Transfusion Adverse Events in Children with Sickle Cell Disease (SCD) Receiving or Automated Red Blood Cell Exchange (arbx) Transfusions for Stroke Prevention Shannon Kelly, M.D. 2 Disclosure

More information

Donor and Patient Care. Leah L. Irwin, RN, MSN, CRNP Nurse Manager of Apheresis, Infusion and Donor Services Transfusion Medicine

Donor and Patient Care. Leah L. Irwin, RN, MSN, CRNP Nurse Manager of Apheresis, Infusion and Donor Services Transfusion Medicine Donor and Patient Care Leah L. Irwin, RN, MSN, CRNP Nurse Manager of Apheresis, Infusion and Donor Services Transfusion Medicine May 3, 2016 Donor and Patient Care Assessment and Monitoring Replacement

More information

Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting

Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting Kim Smith-Whitley, MD Director Comprehensive Sickle Cell Center The Children s

More information

Overview of therapeutic apheresis. Patricia Shi Medical Director, Clinical Services

Overview of therapeutic apheresis. Patricia Shi Medical Director, Clinical Services Overview of therapeutic apheresis Patricia Shi Medical Director, Clinical Services 1 Apheresis principle Greek apairesos: to take away by force access line return line collect/waste line Very different

More information

Erythrocytapheresis vs continuous Manual Exchange Transfusion to treat cerebral macrovasculopathy in children with sickle cell anemia

Erythrocytapheresis vs continuous Manual Exchange Transfusion to treat cerebral macrovasculopathy in children with sickle cell anemia Erythrocytapheresis vs continuous Manual Exchange Transfusion to treat cerebral macrovasculopathy in children with sickle cell anemia Bérengère KOEHL Malika BENKERROU WAA- 26/04/2016 Cerebral vasculopathy

More information

NICE Guidance on Spectra Optia for automated red cell exchange in patients with Sickle Cell Disease

NICE Guidance on Spectra Optia for automated red cell exchange in patients with Sickle Cell Disease NICE Guidance on Spectra Optia for automated red cell exchange in patients with Sickle Cell Disease Dr Jo Howard Guy s and St Thomas NHS Foundation Trust Conflicts of interest Co-investigator/Key opinion

More information

Apheresis Service Annual Haemoglobinopathy Course Sept, 2012

Apheresis Service Annual Haemoglobinopathy Course Sept, 2012 Apheresis Service Annual Haemoglobinopathy Course Sept, 2012 LUHANGA MUSUMADI Clinical Nurse Specialist Lead for Adolescent Transition Guy s & St Thomas NHS Foundation Trust Hospitals Luhanga.Musumadi@gstt.nhs.uk

More information

Blood Group Incompatible Renal Transplantation and Apheresis. Liz Wright Clinical Nurse Specialist Great Ormond Street Hospital NHS FT

Blood Group Incompatible Renal Transplantation and Apheresis. Liz Wright Clinical Nurse Specialist Great Ormond Street Hospital NHS FT Blood Group Incompatible Renal Transplantation and Apheresis Liz Wright Clinical Nurse Specialist Great Ormond Street Hospital NHS FT Background There is growing interest in transplantation across the

More information

Rationale for RBC Transfusion in SCD

Rationale for RBC Transfusion in SCD Rationale for RBC Transfusion in SCD Dilution of HgbS-containing RBCs via the addition of HgbA-containing cells from the blood of normal donors Suppression of erythropoietin release caused by the rise

More information

Victoria Chapman BS, RN, HP (ASCP)

Victoria Chapman BS, RN, HP (ASCP) Victoria Chapman BS, RN, HP (ASCP) Considerations: Age Sex Body Composition Hydration Status Chemotherapy Use Access History Considerations: Immunosuppression Use Chemotherapy Frequency of plasma exchanges

More information

Vascular Access Options for Apheresis Medicine

Vascular Access Options for Apheresis Medicine Vascular Access Options for Apheresis Medicine Josh King, MD Divisions of Nephrology and Medical Toxicology University of Virginia September 21, 2018 Disclosure I have no personal or professional financial

More information

Blood Transfusions in Children with Haemoglobinopathies

Blood Transfusions in Children with Haemoglobinopathies Blood Transfusions in Children with Haemoglobinopathies Version: 2 Date: 22 nd April 2010 Authors: Responsible committee or Director: Review date: Target audience: Stakeholders/ committees involved in

More information

ASH Draft Recommendations for SCD Related Transfusion Support

ASH Draft Recommendations for SCD Related Transfusion Support ASH Draft Recommendations for SCD Related Transfusion Support INTRODUCTION American Society of Hematology (ASH) guidelines are based on a systematic review of available evidence. Through a structured process,

More information

ASFA 2015 Consensus Conference: RBC Exchange in Sickle Cell Disease

ASFA 2015 Consensus Conference: RBC Exchange in Sickle Cell Disease ASFA 2015 Consensus Conference: RBC Exchange in Sickle Cell Disease Session 5B: SELECTION OF RED CELLS Araba Afenyi-Annan, MD, MPH Adjunct Assistant Professor Department of Pathology & Laboratory Medicine,

More information

Blood/Blood Component Utilization and Administration Annual Compliance Education

Blood/Blood Component Utilization and Administration Annual Compliance Education Blood/Blood Component Utilization and Administration Annual Compliance Education This course contains annual compliance education necessary to meet compliance and regulatory requirements. Instructions:

More information

Clinical guideline: manual red cell exchange in patients with sickle cell disease

Clinical guideline: manual red cell exchange in patients with sickle cell disease Clinical guideline: manual red cell exchange in patients with sickle cell disease HN-504b Introduction Most patients with sickle cell anaemia are relatively asymptomatic despite baseline Hb concentrations

More information

White Cell Depletion for Leukocytosis

White Cell Depletion for Leukocytosis White Cell Depletion for Leukocytosis Objectives Discuss the indication for leukoreduction Identify IV access needs for patients receiving leukapheresis Outline ways to maintain fluid and electrolyte balance

More information

SICKLE CELL AWARENESS. The Sickle Cell Society has produced the following information leaflets available at sicklecellsociety.org

SICKLE CELL AWARENESS. The Sickle Cell Society has produced the following information leaflets available at sicklecellsociety.org sickle cell disease in the UK Sickle cell disease (SCD) affects around 15,000 people in the UK People with Sickle Cell Disease have Sickle haemoglobin (HbS) which can make red blood cells rigid and sickle-shaped

More information

Unit 5: Blood Transfusion

Unit 5: Blood Transfusion Unit 5: Blood Transfusion Blood transfusion (BT) therapy: Involves transfusing whole blood or blood components (specific portion or fraction of blood lacking in patient). Learn the concepts behind blood

More information

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion? Blood Components and Transfusions Describe blood components Identify nursing responsibilities r/t blood transfusion Discuss factors r/t blood transfusion including blood typing, Rh factor, and cross matching

More information

Pediatric Red Cell Exchange Indications, Benefits, Barriers. View from California Saturday May 9 th ASFA 2015

Pediatric Red Cell Exchange Indications, Benefits, Barriers. View from California Saturday May 9 th ASFA 2015 Pediatric Red Cell Exchange Indications, Benefits, Barriers View from California Saturday May 9 th ASFA 2015 Red Cell Exchange: Not SCD Recommendations for Red Cell Exchange Indication Procedure Recommendation

More information

Diagnosis: Allergies with reaction type:

Diagnosis: Allergies with reaction type: Patient Name: Diagnosis: Allergies with reaction type: CHRONIC HOME HEMODIALYIS ORDERS Version 4 1/21/2013 1. TREATMENT ORDERS A. Frequency of treatment 5 6 times per week. B. Weight and blood pressures,

More information

Welcome to esessions. Presented by CaridianBCT. PN CaridianBCT

Welcome to esessions. Presented by CaridianBCT. PN CaridianBCT Welcome to esessions Presented by CaridianBCT Presentation Overview Definition of TPE Rationale for TPE Role of TPE in the treatment of autoimmune diseases Procedural elements Definition of TPE Removal

More information

Hind Al Humaidan, MD, FRCPA Consultant Hematopathologist Director, Blood Bank (DS & TS) / Stem Cell Cord Blood Bank Department of Pathology and

Hind Al Humaidan, MD, FRCPA Consultant Hematopathologist Director, Blood Bank (DS & TS) / Stem Cell Cord Blood Bank Department of Pathology and Guidelines on the Use of Therapeutic Apheresis in Clinical Practice Evidence Based Approach from the Writing Committee of the American Society for Apheresis: The 7th Special Issue Hind Al Humaidan, MD,

More information

Risks and Benefits of Blood Transfusions. Objectives. Red Cells (Erythrocytes) Understand the following:

Risks and Benefits of Blood Transfusions. Objectives. Red Cells (Erythrocytes) Understand the following: Risks and Benefits of Blood Transfusions Patient and Family Conference Aplastic Anemia & MDS International Foundation July 10-12 th, 2009 Indianapolis, Indiana Susan M. Carson RN, MSN, CPNP Childrens Hospital

More information

Venous Access in Apheresis. Daniel Putensen, Apheresis Nurse

Venous Access in Apheresis. Daniel Putensen, Apheresis Nurse Venous Access in Apheresis Daniel Putensen, Apheresis Nurse Why is Vascular Access so important? Henrikson et al. Adverse events in apheresis: An update of the WAA registry data.transfus Apher Sci. 2016;

More information

2019 Home Hemodialysis Standing Orders

2019 Home Hemodialysis Standing Orders 2019 Home Hemodialysis Standing Orders 1. Nutrition Standards of Care: A. Follow P&P Nutrition Standards of Care 2. Laboratory Tests: A. Drawn On Admission: 1. Renal Function Panel (BMP, PO 4 and Albumin)

More information

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE

More information

Plasma exchange. Information for patients Sheffield Kidney Institute (Renal Unit)

Plasma exchange. Information for patients Sheffield Kidney Institute (Renal Unit) Plasma exchange Information for patients Sheffield Kidney Institute (Renal Unit) Plasma exchange This leaflet explains about plasma exchange; the benefits, risks, alternatives and what you can expect when

More information

IV therapy. By: Susan Mberenga, RN, MSN. Copyright 2016, 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.

IV therapy. By: Susan Mberenga, RN, MSN. Copyright 2016, 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. IV therapy By: Susan Mberenga, RN, MSN 1 IV Therapy Types of solutions Isotonic Hypotonic Hypertonic Caution: Too rapid or excessive infusion of any IV fluid has the potential to cause serious problems

More information

National Institute for Health and Care Excellence Medical Technologies Evaluation Programme

National Institute for Health and Care Excellence Medical Technologies Evaluation Programme National Institute for Health and Care Excellence Medical Technologies Evaluation Programme MT271 Spectra Optia Apheresis System for automated red blood cell exchange in patients with sickle cell disease

More information

Apheresis in Hematology (Erythrocytapheresis in Sickle Cell Disease) Haewon C. Kim, M.D.

Apheresis in Hematology (Erythrocytapheresis in Sickle Cell Disease) Haewon C. Kim, M.D. Apheresis in Hematology (Erythrocytapheresis in Sickle Cell Disease) Haewon C. Kim, M.D. The Children s Hospital of Philadelphia Perelman School of Medicine University of Pennsylvania Philadelphia, PA,

More information

Webinar: Association of Hgb A Clearance & RBC Antibodies

Webinar: Association of Hgb A Clearance & RBC Antibodies Webinar: Association of Hgb A Clearance & RBC Antibodies Second Webinar Session A second session of this webinar will be hosted Wednesday, July 12 2:00 PM EST (1800 GMT) Register at the link below: https://attendee.gotowebinar.com/rt/9012031991808089089

More information

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS PRACTICE POINTS Give the right blood product to the right patient at the right time. Failure to correctly check the patient or the pack can be fatal. At the

More information

Photopheresis Technical Challenges. Lindsay Palomino, BSN RN HP May 6, 2016

Photopheresis Technical Challenges. Lindsay Palomino, BSN RN HP May 6, 2016 Photopheresis Technical Challenges Lindsay Palomino, BSN RN HP May 6, 2016 No relevant disclosures SCCA Apheresis Unit! Therakos CellEx Photopheresis System For technical challenges and troubleshooting:

More information

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO. LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual

More information

34 th Annual Meeting of ASFA, May 22-25, 2013, Denver, CO

34 th Annual Meeting of ASFA, May 22-25, 2013, Denver, CO 34 th Annual Meeting of ASFA, May 22-25, 2013, Denver, CO Conflict of Interest F. Tekin Turhan has received consulting, travel and accommodation support from Terumo BCT Co-authors have nothing to declare

More information

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National

More information

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give? Components of Blood Formed elements Cells Erythrocytes (RBCs) Leukocytes (WBCs) Thrombocytes (platelets) Plasma 90% water 10% solutes Proteins, clotting factors 1 What can we give? Whole blood Packed RBC

More information

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015 Transfusion Medicine Potpourri BUMC - Phoenix Internal Medicine Residents September 29, 2015 Clinical case A 24 year old female with sickle cell anemia has just moved to the area and presents as a new

More information

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease A Pocket Guide for the Clinician Susan E. Creary, MD, MSc 1 John J. Strouse, MD, PhD 2 1 The Ohio State University School of

More information

A PRIMER ON APHERESIS MEDICINE

A PRIMER ON APHERESIS MEDICINE A PRIMER ON APHERESIS MEDICINE Nicole Aqui, M.D. Assistant Professor Division of Transfusion Medicine Department of Pathology and Laboratory Medicine University of Pennsylvania What is Apheresis? Apheresis

More information

Transfusions in Sickle Cell Disease: How, When and Why

Transfusions in Sickle Cell Disease: How, When and Why Transfusions in Sickle Cell Disease: How, When and Why James R. Eckman, MD Professor Emeritus of Hematology and Medical Oncology Emory University School of Medicine This work is supported by the Centers

More information

More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells

More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells Thibodeaux, SR, Jamensky, L, Schell K, Irwin L, O Doherty U Hospital of the University of Pennsylvania

More information

Optimal RBC products for RBC exchange for patients with sickle cell disease

Optimal RBC products for RBC exchange for patients with sickle cell disease Optimal RBC products for RBC exchange for patients with sickle cell disease Stella T. Chou, MD ASFA Annual Meeting Fort Lauderdale, FL May 6, 2016 I have no conflicts of interest to disclose Outline Apheresis

More information

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.

More information

Adult Home Hemodialysis Standing Orders

Adult Home Hemodialysis Standing Orders Adult Home Hemodialysis Standing Orders 1. Target Weight All new patients will have an initial assessment. 2. Access: a. Cannulation of AV Fistulas In order to initiate cannulation of a new AV Fistula,

More information

Blood transfusion as a management strategy for Haemoglobinopathy. Corrina McMahon Our Lady s Children s Hospital, Dublin, Ireland

Blood transfusion as a management strategy for Haemoglobinopathy. Corrina McMahon Our Lady s Children s Hospital, Dublin, Ireland Blood transfusion as a management strategy for Haemoglobinopathy Corrina McMahon Our Lady s Children s Hospital, Dublin, Ireland Rationale for BT Sickle cell Disease Reduce the production of Hb Significant

More information

WHAT DO I NEED TO KNOW ABOUT MY VASCULAR ACCESS? FISTULA/GRAFT

WHAT DO I NEED TO KNOW ABOUT MY VASCULAR ACCESS? FISTULA/GRAFT WHAT DO I NEED TO KNOW ABOUT MY VASCULAR ACCESS? FISTULA/GRAFT WHY DO I NEED VASCULAR ACCESS? For dialysis to work properly we need to create a way to take blood from your body, pass it through the dialyzer,

More information

General Characterisctics

General Characterisctics Anemia General Characterisctics Definition: anemia is a decrease in red blood cells. Happens due to underproduction, increased destruction or loss of red cells. Diagnosis of anemia: Hgb < 135 (men) Hgb

More information

Clinical decision making: Red blood cell alloantibodies

Clinical decision making: Red blood cell alloantibodies Clinical decision making: Red blood cell alloantibodies Beth H. Shaz, MD Chief Medical Officer, VP New York Blood Center; Clinical Associate Professor Emory University School of Medicine 1 5 non-abo fatal

More information

Susan L. Pinkard, RN Manager, Therapeutic Apheresis Hoxworth Blood Center University Of Cincinnati Academic Health Center Cincinnati, Ohio

Susan L. Pinkard, RN Manager, Therapeutic Apheresis Hoxworth Blood Center University Of Cincinnati Academic Health Center Cincinnati, Ohio Susan L. Pinkard, RN Manager, Therapeutic Apheresis Hoxworth Blood Center University Of Cincinnati Academic Health Center Cincinnati, Ohio The Good: What indications we using to initiate photopheresis

More information

Chapter 6: Blood Transfusion in the Management of Sickle Cell Disease

Chapter 6: Blood Transfusion in the Management of Sickle Cell Disease Chapter 6: Blood Transfusion in the Management of Sickle Cell Disease Introduction Donor erythrocyte (red blood cell, RBC) transfusion was the first therapy used in SCD that targets the pathophysiology

More information

Meeting the Challenging Transfusion Needs of a Diverse Patient Population

Meeting the Challenging Transfusion Needs of a Diverse Patient Population Presented by: Christy P. Beal Manager, Immunohematology Reference Laboratory American Red Cross Blood Services Southern Region, Douglasville, GA Southeastern Area Blood Bankers Meeting March 24, 2017 Objectives

More information

STEM CELL TRANSPLANT IN PEDIATRICS. Erin Meyer, DO, MPH Medical Director, Apheresis Nationwide Children s Hospital Columbus, OH 5/6/17

STEM CELL TRANSPLANT IN PEDIATRICS. Erin Meyer, DO, MPH Medical Director, Apheresis Nationwide Children s Hospital Columbus, OH 5/6/17 STEM CELL TRANSPLANT IN PEDIATRICS Erin Meyer, DO, MPH Medical Director, Apheresis Nationwide Children s Hospital Columbus, OH 5/6/17 Disclosures Nothing to Disclose Overview Stem Cell Transplant History

More information

Management of the patient with established AKI. Kelly Wright Lead Nurse for AKI King s College Hospital

Management of the patient with established AKI. Kelly Wright Lead Nurse for AKI King s College Hospital Management of the patient with established AKI Kelly Wright Lead Nurse for AKI King s College Hospital Medical management Medical management Respiratory- pulmonary oedema, repositioning- upright, oxygen

More information

VASCULAR ACCESS. Arterio-venous fistula. Central venous catheter. Arterio-venous graft

VASCULAR ACCESS. Arterio-venous fistula. Central venous catheter. Arterio-venous graft VASCULAR ACCESS 1 Vascular access is the route into your bloodstream that allows you to be connected to the dialysis machine which removes and returns your blood after it has been cleaned. There are three

More information

Consent Laboratory Transfuse RBC

Consent Laboratory  Transfuse RBC Peds Blood Product Infusion Order Set (386) [386] Blood product review will be performed unless exclusion criteria met. MD: Please note if transfusion giv en outside of parameter, please justify use in

More information

The use of red cell genotyping in the management of sickle cell disease

The use of red cell genotyping in the management of sickle cell disease The use of red cell genotyping in the management of sickle cell disease Dr Sara Trompeter Consultant Haematologist UCLH and NHSBT Dr Keir Pickard Core Medical Trainee UCLH British Blood Transfusion Society

More information

The Child with a Hematologic Alteration

The Child with a Hematologic Alteration 47 The Child with a Hematologic Alteration HELPFUL HINT Review the anatomy and physiology of the hematologic system in an anatomy and physiology textbook. MATCHING KEY TERMS Match the term with the correct

More information

Provision of Red Cell Transfusion Support for Transfusion Dependent Patients

Provision of Red Cell Transfusion Support for Transfusion Dependent Patients 1.0 Definition Transfusion dependent patients are those who require frequent and long-term transfusion support to sustain life. Most such patients have been diagnosed with one of the following conditions:

More information

Adult Home Hemodialysis Standing Orders

Adult Home Hemodialysis Standing Orders Adult Home Hemodialysis Standing Orders 1. Target Weight All new patients will have an initial assessment. 2. Access a. Cannulation of AV Fistulas In order to initiate cannulation of a new AV Fistula,

More information

Apheresis red cell exchange and transfusion therapy for management of sickle cell disease. Dr Paul Telfer

Apheresis red cell exchange and transfusion therapy for management of sickle cell disease. Dr Paul Telfer Apheresis red cell exchange and transfusion therapy for management of sickle cell disease Dr Paul Telfer OVERVIEW Pathophysiology and epidemiology Physiological and clinical considerations prior to transfusion

More information

Making Hope A Reality December 10, Nasdaq : BLUE

Making Hope A Reality December 10, Nasdaq : BLUE Making Hope A Reality December 10, 2014 Nasdaq : BLUE Forward Looking Statement These slides and the accompanying oral presentation contain forward-looking statements and information. The use of words

More information

Apheresis: Transfusion Indications. Sasha Wilson: Transfusion Senior Nurse

Apheresis: Transfusion Indications. Sasha Wilson: Transfusion Senior Nurse Apheresis: Transfusion Indications Sasha Wilson: Transfusion Senior Nurse Apheresis: Transfusion Indications Focus of talk will be blood component transfusion in the context of apheresis procedures: Special

More information

mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).

mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20). S44 Figure 53 depicts the trend in Epoetin dosing from the 1998 study period to the 2003 study period, with an increasing mean weekly Epoetin dose (units/kg/wk) for patients prescribed Epoetin in lower

More information

Comparison of Spectra Optia and COBE Spectra apheresis systems performances for Red Blood Cell Exchange procedures

Comparison of Spectra Optia and COBE Spectra apheresis systems performances for Red Blood Cell Exchange procedures Comparison of and COBE apheresis systems performances for Red Blood Cell Exchange procedures Jaehyup Kim MD PhD UT Southwestern Medical Center COBE and COBE (Terumo BCT, Lakewood, Co) has been the mainstay

More information

WHAT DO I NEED TO KNOW ABOUT MY VASCULAR ACCESS? CATHETER

WHAT DO I NEED TO KNOW ABOUT MY VASCULAR ACCESS? CATHETER WHAT DO I NEED TO KNOW ABOUT MY VASCULAR ACCESS? CATHETER WHY DO I NEED VASCULAR ACCESS? For dialysis to work properly we need to create a way to take blood from your body, pass it through the dialyzer,

More information

Transfusion in Sickle Cell Disease What the guidelines [are likely to] say. Dr Bernard Davis Whittington Hospital, London

Transfusion in Sickle Cell Disease What the guidelines [are likely to] say. Dr Bernard Davis Whittington Hospital, London Transfusion in Sickle Cell Disease What the guidelines [are likely to] say Dr Bernard Davis Whittington Hospital, London Background to BCSH Guideline Rationale Current guidance in disparate publications

More information

Advancing Lives and the Delivery of Health Care. The High-Flow Port Designed for Apheresis

Advancing Lives and the Delivery of Health Care. The High-Flow Port Designed for Apheresis Advancing Lives and the Delivery of Health Care The High-Flow Port Designed for Apheresis Optimized for Long Device Life Bench Tested up to 1,000 Accesses 1 Bard is proud to introduce the first and only

More information

ANEMIA OF CHRONIC KIDNEY DISEASE

ANEMIA OF CHRONIC KIDNEY DISEASE Understanding Your Hemodialysis Access Options UNDERSTANDING ANEMIA OF CHRONIC KIDNEY DISEASE UNDERSTANDING ANEMIA OF CHRONIC KIDNEY DISEASE WHAT IS CHRONIC KIDNEY DISEASE (CKD)? When someone has CKD,

More information

1 Kattamis et al. Growth of Children with Thalassemia: Effect of Different Transfusion Regimens. Archives of

1 Kattamis et al. Growth of Children with Thalassemia: Effect of Different Transfusion Regimens. Archives of Objectives Sickle Cell Anemia and Thalassemia: Transplantation Provide overview of hemoglobinopathies: Sickle cell disease and Thalassemia Discuss approaches to therapy Review recent registry collaboration

More information

IR Central Venous Access [ ] Pre Procedure

IR Central Venous Access [ ] Pre Procedure IR Central Venous Access [1050200001] Pre Procedure Case Request/Scheduling Procedure Enter IR Case Request if not already completed (All hospitals except Grant Medical Center) [ ] Case Request IR Lab

More information

ECMO vs. CPB for Intraoperative Support: How do you Choose?

ECMO vs. CPB for Intraoperative Support: How do you Choose? ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon

More information

2017 AABB Annual Meeting On-Demand Select Patient Blood Management & Related Sessions

2017 AABB Annual Meeting On-Demand Select Patient Blood Management & Related Sessions 2017 AABB Annual Meeting On-Demand Select Patient Blood Management & Related Sessions The following 15 Patient Blood Management (PBM) and topics of interest for PBM professionals are eligible for up to

More information

Haemodialysis. Patient Information. Working together for better patient information. Health & care information you can trust. The Information Standard

Haemodialysis. Patient Information. Working together for better patient information. Health & care information you can trust. The Information Standard Haemodialysis Patient Information Health & care information you can trust The Information Standard Certified Member Working together for better patient information Haemodialysis (HD) helps to remove the

More information

Family Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm

Family Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm Family Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm Decision 1: Triage Decision 2: Analgesic Management Decision 3: Diagnostic

More information

Vascular Access for Haemodialysis. Mike Stephens

Vascular Access for Haemodialysis. Mike Stephens Vascular Access for Haemodialysis Mike Stephens Overview Learning Objectives History and development of vascular access Standards in vascular access surgery Types of vascular access Complications Objectives

More information

Physiology. Apheresis. ECV Fluid compartments Replacement of collected volume Calcium / Magnesium metabolism Use of citrate / heparine

Physiology. Apheresis. ECV Fluid compartments Replacement of collected volume Calcium / Magnesium metabolism Use of citrate / heparine Program Physiology ECV Fluid compartments Replacement of collected volume Calcium / Magnesium metabolism Use of citrate / heparine Apheresis 1 2 ECV ECV Extra corporeal volume Volume of blood removed from

More information

Active UMMC Protocols

Active UMMC Protocols UMMC CRRT 2018 Active UMMC Protocols 1. Standard CRRT Protocol PrismaFlex & NxStage CVVH with Fixed Ratio Regional Citrate Anticoagulation 2. No Anticoagulation Protocol PrismaFlex & NxStage CVVH with

More information

Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications

Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)

More information

COHEM Barcellona 2012 Hemoglobinopathies debate

COHEM Barcellona 2012 Hemoglobinopathies debate COHEM Barcellona 2012 Hemoglobinopathies debate September 8, 2012: h. 10:30-12:00 Hall: A Is it justified to perform BMT in hemoglobinopathies using unrelated and/or partially mismatched donors? HSCT indication

More information

CURRENT RESEARCH STUDIES

CURRENT RESEARCH STUDIES CURRENT RESEARCH STUDIES SCAGO SICKLE CELL RESEARCH DAY MAY 12, 2018 REBECCA LEROUX RN, BSCN, CCRP RED BLOOD CELL DISORDERS PROGRAM, UNIVERSITY HEALTH NETWORK MANUELA MERELLES-PULCINI RN, BSCN, MSN, CCRP

More information

Dependance on chronic transfusion

Dependance on chronic transfusion Dependance on chronic transfusion Pr Saliou Diop Hematology Blood transfusion Dakar- Sénégal diop@cnts-dakar.sn Introduction Chronic transfusion: Regular use of blood transfusion in patients with chronic

More information

About Implanted Ports

About Implanted Ports PATIENT & CAREGIVER EDUCATION About Your Implanted Port This information will teach you about the placement and care of your implanted port. An implanted port is a type of central venous catheter (CVC).

More information

Transfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium

Transfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium Transfusion Practices and Creation of a Registry for Patients with Sickle Cell Disease within the Atlanta Sickle Cell Consortium Annie Winkler MD Assistant Professor, Emory University Department of Pathology

More information

FerriScan provides an accurate assessment of body iron stores

FerriScan provides an accurate assessment of body iron stores FerriScan provides an accurate assessment of body iron stores A clinician s guide to managing transfusional iron overload with FerriScan Transfusional iron overload Patients receiving multiple blood transfusions

More information

Consensus view on choice or iron chelation therapy in transfusional iron overload for inherited anaemias

Consensus view on choice or iron chelation therapy in transfusional iron overload for inherited anaemias Consensus view on choice or iron chelation therapy in transfusional iron overload for inherited anaemias The goal of iron chelation therapy in multiply transfused patients is to prevent morbidity and early

More information

Clinical Guidelines on the Use of Iron Chelation in Children Receiving Regular Blood Transfusions

Clinical Guidelines on the Use of Iron Chelation in Children Receiving Regular Blood Transfusions Clinical Guidelines on the Use of Iron Chelation in Children Receiving Regular Blood Transfusions Version: 1 Date: 4 th May 2010 Authors: Responsible committee or Director: Review date: Target audience:

More information

RED BLOOD CELL EXCHANGE IN SICKLE CELL DISEASE A CONSENSUS CONFERENCE at the ASFA 2015 Annual Meeting

RED BLOOD CELL EXCHANGE IN SICKLE CELL DISEASE A CONSENSUS CONFERENCE at the ASFA 2015 Annual Meeting RED BLOOD CELL EXCHANGE IN SICKLE CELL DISEASE A CONSENSUS CONFERENCE 2015 Grand Hyatt May 5th, 2015 AN EDUCATIONAL AND NETWORKING FORUM FOR PROFESSIONALS IN THE FIELD OF APHERESIS MEDICINE SAN ANTONIO,

More information

Therapeutic Leukocyte Reduction (TLR) For Myeloid Leukaemia's : A Four Year Experience From An Oncology Centre In India

Therapeutic Leukocyte Reduction (TLR) For Myeloid Leukaemia's : A Four Year Experience From An Oncology Centre In India Therapeutic Leukocyte Reduction (TLR) For Myeloid Leukaemia's : A Four Year Experience From An Oncology Centre In India Anita Tendulkar, Jain P, Gupta A, Sharma N, Navkudkar A, Patle V Dr Anita Tendulkar

More information

Clinical Performance Goals

Clinical Performance Goals Clinical Performance Goals 2011-2012 Clinical Performance Goals 2011-2012 Table of Contents Table of Contents... 1 Health Care Quality Improvement Program... 2 Clinical Performance Measures... 6 Chapter

More information

ASDIN 10th Annual Scientific Meeting Final

ASDIN 10th Annual Scientific Meeting Final Cost Saving Techniques for Outpatient Vascular Access Centers ASDIN 2014 Annual Meeting Phoenix, AZ Jeffrey Hoggard MD FACP FASN Capital Nephrology Associates Raleigh, NC Conflicts of Interest Medical

More information

Fistula/Graft Protection. Leslie Dork Renal Medicine Associates

Fistula/Graft Protection. Leslie Dork Renal Medicine Associates + Fistula/Graft Protection Leslie Dork Renal Medicine Associates + Disclaimer Renal Medicine Associates employee I have no conflicts of interest. + Access failure Infections Infiltrations Stenoses/Thrombosis

More information

Lesson #7: Quality Assessment and Performance Improvement

Lesson #7: Quality Assessment and Performance Improvement ESRD Update: Transitioning to New ESRD Conditions for Coverage Student Manual Lesson #7: Quality Assessment and Performance Improvement Learning Objectives At the conclusion of this lesson, you will be

More information

Exchange Transfusion

Exchange Transfusion Approved by: Exchange Transfusion Gail Cameron Director, Maternal, Neonatal & Child Health Programs Neonatal Nursery Policy & Procedures Manual : Next Review March 2016 Dr. Ensenat Medical Director, Neonatology

More information

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Objective: The student should be able: To identify the presentation, diagnosis,

More information

The High-Flow Port Designed & Indicated for Apheresis

The High-Flow Port Designed & Indicated for Apheresis The High-Flow Port Designed & Indicated for Apheresis Advancing Lives and the Delivery of Health Care Bard is proud to introduce the first and only high-flow, power-injectable port designed and indicated

More information